SCHEMBL7654214

SCHEMBL7654214

CC=Cc1ccc(F)c(F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 3/20 0.63
CNR2 P34972 1/20 0.48
PABPC1 P11940 1/20 0.47
RAB9A P51151 1/20 0.47
EIF4H Q15056 1/20 0.47
CYP3A4 P08684 2/20 0.44
ATM Q13315 1/20 0.44
PTGS2 P35354 1/20 0.44
TYR P14679 1/20 0.42
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TUBB1 Q9H4B7 4/20 0.41
PDK2 Q15119 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TRPA1 O75762 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654210 1.00 NFE2L2 (0.63) NFE2L2CNR2PABPC1RAB9AEIF4H
SCHEMBL7655780 1.00 NFE2L2 (0.63) NFE2L2CNR2PABPC1RAB9AEIF4H
SCHEMBL10624527 0.82 TUBB1 (0.49) NFE2L2CNR2CYP3A4ATMPTGS2
SCHEMBL12506745 0.82 TUBB1 (0.49) NFE2L2CNR2CYP3A4ATMPTGS2
SCHEMBL16953105 0.82 NFE2L2 (0.48) NFE2L2CNR2CYP3A4ATMPTGS2
SCHEMBL24697613 0.80 ALDH1A1 (0.46) NFE2L2CNR2CYP3A4ATMTYR
SCHEMBL11599639 0.80 CNR2 (0.64) NFE2L2CNR2RAB9ACYP3A4ATM
SCHEMBL2660226 0.80 VCP (0.56) NFE2L2CNR2RAB9ACYP3A4ATM
SCHEMBL15232822 0.80 CNR2 (0.44) NFE2L2CNR2CYP3A4ATMTYR
SCHEMBL2660229 0.80 VCP (0.56) NFE2L2CNR2RAB9ACYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
US-20140058120-A1 TRI-SUBSTITUTED 2-BENZHYDRYL-5-BENZYLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES WAYNE STATE UNIVERSITY (US) 2014-02-27 US disclosed
US-6372911-B1 REACTING COMPOUND CONTAINING AT LEAST ONE CARBON-CARBON DOUBLE BOND WITH CARBAMATE IN AQUEOUS SOLVENT IN PRESENCE OF BASE, OSMIUM CATALYST, CO-OXIDANT, AND OPTIONALLY ASYMMETRIC LIGAND, TO FORM REACTION MIXTURE CONTAINING BETA-HYDROXY CARBAMATE MERCK & CO., INC. 2002-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140058120-A1 TRI-SUBSTITUTED 2-BENZHYDRYL-5-BENZYLAMINO-TETRAHYDRO-PYRAN-4-OL AND 6-BENZHYDRYL-4-BENZYLAMINO-TETRAHYDRO-PYRAN-3-OL ANALOGUES, AND NOVEL 3,6-DISUBSTITUTED PYRAN DERIVATIVES TPH1, HTR4, TPH2 NFE2L2 2627/4885CNR2 276/4885PABPC1 2321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.